FibroGen Stock Was Up By 14.69% Before The Weekend
(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) rising 14.69% to $2.73 on Friday while NASDAQ jumped 1.25% to $15,990.66. FibroGen’s last close was $2.38, 90.73% under its 52-week high of $25.68. About FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product…